Summary
- Current Price
- As of today, CBIO price is $11.74, up +20.78% on
- Current Price All-Time High
- CBIO price is currently -99.55% below its historical high of $2,605.00 set on
- Market Cap
- CBIO current market cap is $357M, up +1687.40% over the past 365 days
- PE Ratio
- CBIO PE ratio is unknown
- Revenue
- CBIO current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- As of today, the next earnings release for CBIO has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Crescent Biopharma, Inc. |
| Ticker | NASDAQ: CBIO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | crescentbiopharma.com |
| Employees | 6 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $11.74 | ||
| Price, 1D Change | +20.78% | |
| $357M | ||
| - | ||
| - | ||
| 1.00 | ||
| $0 | ||
| Revenue, 1Y Change | -100.00% | |
| -$58.75 | ||
| EPS, 1Y Change | -0.85% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:100 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GLYC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$58.75 | ||
| EPS Estimate | N/A | -$7.92 |
| EPS Est. Change | N/A | +86.53% |
| $0.00 | ||
| Revenue Estimate | N/A | $7.50M |
| Revenue Est. Change | N/A | - |
| $11.74 | ||
| Price Target | - | $32.00 |
| Price Tgt. Change | - | +172.57% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.16 | -$58.25 | -36,308.75% | |
| -$0.03 | -$58.75 | -195,726.67% | |
| -$7.92 | N/A | +86.53% | |
| -$3.31 | N/A | +94.36% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $10.00K | - | |
| - | $0.00 | - | |
| $7.50M | N/A | - | |
| $2.63M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -62.13% | ||
| -93.76% | ||
| +1,687.40% | ||
| +249.63% | ||
| -100.00% | ||
| -100.00% | ||
| -0.85% | ||
| +52.34% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $11.74 | ||
| $14.13 | ||
| SMA 200 vs Price | +20.40% | |
| $11.56 | ||
| SMA 50 vs Price | -1.52% | |
| 1.00 | ||
| $0.93 | ||
| 60.30 | ||
| 112.22% | ||
| 73.92% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$58.75 | ||
| -$35.20K | ||
| - | ||
| -$32.51M | ||
| - | ||
| -$37.88M | ||
| - | ||
| -$32.47M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 1.92 | ||
| 1.92 | ||
| - | ||
| - | ||
| -34.38 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 3.17 | ||
| -4.14 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $5.31M | ||
| $10.72M | ||
| $11.09M | ||
| $11.09M | ||
| $5.78M | ||
| $5.78M | ||
| $66.80K | ||
| $66.80K | ||
| $329.30K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $37.88M | ||
| $32.47M | ||
| $35.20K | ||
| $0.00 | ||
| $35.20K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$31.10M | ||
| $20.00K | ||
| $5,400.00 | ||
| $10.00K | ||
| -$31.11M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | ||
| HC Wainwright & Co. | → | |
| Jefferies | ||
| HC Wainwright & Co. | ||
| Wedbush | ||
| Stifel | ||
| LifeSci Capital | ||
| Raymond James | → | |
| Raymond James | ||
| Raymond James |
Analyst sentiment
Institutional ownership
Screeners with CBIO
FAQ
What is the ticker symbol for Crescent Biopharma, Inc.?
The ticker symbol for Crescent Biopharma, Inc. is NASDAQ:CBIO
Does Crescent Biopharma, Inc. pay dividends?
No, Crescent Biopharma, Inc. does not pay dividends
What sector is Crescent Biopharma, Inc. in?
Crescent Biopharma, Inc. is in the Healthcare sector
What industry is Crescent Biopharma, Inc. in?
Crescent Biopharma, Inc. is in the Biotechnology industry
What country is Crescent Biopharma, Inc. based in?
Crescent Biopharma, Inc. is headquartered in United States
When did Crescent Biopharma, Inc. go public?
Crescent Biopharma, Inc. initial public offering (IPO) was on January 10, 2014
Is Crescent Biopharma, Inc. in the S&P 500?
No, Crescent Biopharma, Inc. is not included in the S&P 500 index
Is Crescent Biopharma, Inc. in the NASDAQ 100?
No, Crescent Biopharma, Inc. is not included in the NASDAQ 100 index
Is Crescent Biopharma, Inc. in the Dow Jones?
No, Crescent Biopharma, Inc. is not included in the Dow Jones index
When was Crescent Biopharma, Inc. last earnings report?
Crescent Biopharma, Inc.'s most recent earnings report was on August 2, 2018
When does Crescent Biopharma, Inc. report earnings?
The date for Crescent Biopharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CBIO Official Website crescentbiopharma.com
- CBIO Profile on Yahoo Finance finance.yahoo.com/quote/CBIO
- CBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cbio